Searched for
SUN PHARMA EYE DROPS RECALL
Sun Pharma recalls eye drops in India after contamination scare"Withdrawal of Product - Depopred2ML, Brinolar (BKC FREE), Brinzotim Eye Drops 5ML BKC FREE, Lotepred-5ML, Lotepred 1% Eye Drops SML, Lotep...- In 1995, Turkish truck driver Sehmus Erginoglu began clearing rubbish and watering saplings; 25 years later, a former Mardin dump had become a small forestA retired truck driver named Sehmus Erginoglu planted thousands of trees on neglected land. He spent twenty-five years transforming a local...
- Upcoming Meteor Showers, Two Eclipse Are Taking Place In August 2026: Everything You Need to Know About the Solar and Lunar EclipsesAugust 2026 will host two celestial events, a solar eclipse and a lunar eclipse. These occurrences mark an eclipse season, a period of cele...
- Sun Pharma Q1 Results: Profit rises 27% YoY to Rs 2,895 crore; revenue climbs 10.5%Sun Pharma Q1 Results: Sun Pharma reported a 27% YoY rise in Q1 net profit to Rs 2,895 crore, while revenue grew 10% to Rs 15,300 crore, dr...
- FDA recalls over 11 million Rohto eye drop cartons nationwide over sterility concernsMillions of Rohto eye drops are being recalled across the United States. The FDA classified a nationwide recall involving popular products ...
- Stocks in news: Maruti Suzuki, ITC, Vedanta, Swiggy, RILIndian markets traded in a narrow range, settling marginally higher with mixed cues. Maruti Suzuki, ITC, and Vedanta shares are in focus du...
- Sun Pharma among 7 stocks to hit 52-week highs & surge up to 20% in a monthSeven BSE 100 stocks, including TVS Motor, Divi's Laboratories and Nestle India, touched fresh 52-week highs as Sensex gained 273 points. T...
- India takes action against 90% of inspected high-risk pharmaceutical facilities, regulator saysAmid increasing global concerns over Indian pharmaceuticals, India's drug regulator is rigorously addressing high-risk manufacturing sites....
- How AI is helping pharma prevent drug recalls, counter fakes and improve patient safetyArtificial intelligence is revolutionizing the pharmaceutical sector by significantly reducing the instances of drug recalls. By improving ...
- ‘I was a lovesick character’: Ruskin Bond opens up on his first heartbreak. Author shares how a Vietnamese woman rejected his marriage proposalAuthor Ruskin Bond shared a past heartbreak from his youth. He recounted a Vietnamese woman rejecting his marriage proposal based on tea le...
- Meteor showers to light up the UK night sky as Delta Aquariid peaks this week after the Buck Moon. Here's when and how to watch both celestial events at their best.Meteor showers: Skywatchers are in for a spectacular week as two major celestial events light up the night sky. The Buck Moon, July's full ...
- Tariff on generic drugs: Loud announcement, little consequence? 7 pharma stocks with upside potential of up to 31%The threat of a US tariff on Indian pharma is no longer a vague fear; or at least that is what President Trump wants us to believe. There i...
- US tariff proposal wake-up call for Indian pharma to diversify, innovate: ExpertsUS pharma tariffs: Experts have urged a shift towards global diversification and prioritising innovation for Indian pharma to lessen market...
- Pharma deal activity hits four-quarter low, but mega Sun Pharma acquisition drives valueIndia's pharma and healthcare sector recorded 65 deals worth $13.9 billion in Q2 CY2026, with volumes falling 17% quarter-on-quarter to a f...
- ‘If you truly believe in your dream…’: Anupam Kher’s heartfelt message to his 25-year-old self is a lesson on battling fears and showing up despite challengesAnupam Kher shared throwback photos from the first time he arrived in Mumbai in 1981. He recalled feeling overwhelmed by the vastness of th...
- Organon shareholders approve Sun Pharma's $11.75-bn acquisition proposalSun Pharmaceutical Industries Ltd announced shareholder approval for its Organon & Co acquisition. This significant milestone moves the pro...
- Why did market fall today? 7 triggers behind Rs 4 lakh crore wealth wipeoutIndian stock markets experienced significant declines on Wednesday. Escalating Iran-US tensions and tariff threats spooked investors, causi...
- Explained: What Donald Trump's up to 200% pharma tariffs mean for Indian investorsDonald Trump's announcement of tariffs of up to 200% on pharmaceutical imports triggered a selloff in Indian pharma stocks. However, analys...
- Trump announces new generic drugs tariff plan: No tariffs for 2 years, then 100%, and then 200%For Indian exporters, the two-year tariff-free period offers additional time to reassess supply chains and investment plans. While the imme...
- Sun Pharma, Cipla & other pharma stocks shed over 2% as Trump announces up to 200% tariffs on generic drugs from 2028Pharma stocks, including Sun Pharma, Cipla, Lupin and Dr Reddy's, fell up to 2.5% after US President Donald Trump announced a phased tariff...
Load More
